Back
Gilead Sciences Vs. Rhythm Pharmaceuticals Industry Stock Comparison
Buy
63
GILD
Gilead Sciences
Last Price:
$101.40
Seasonality Move:
4.45%
Sell
50
RYTM
Rhythm Pharmaceuticals
Last Price:
$56.77
Seasonality Move:
54.9%
Buy
63
Gilead Sciences (GILD)
is a Buy
Is Gilead Sciences a Buy, Sell or Hold?
-
The current Gilead Sciences [GILD] share price is $103.82. The Score for GILD is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
-
GILD is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
50
Rhythm Pharmaceuticals (RYTM)
is a Sell
Is Rhythm Pharmaceuticals a Buy, Sell or Hold?
-
The current Rhythm Pharmaceuticals [RYTM] share price is $58.97. The Score for RYTM is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
RYTM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GILD Stock Price Chart
What is Gilead Sciences's stock price today?
-
The Gilead Sciences share price today is $103.82Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GILD is experiencing buying pressure, which is a positive indicator for future bullish movement.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals's stock price today?
-
The Rhythm Pharmaceuticals share price today is $58.97Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RYTM is experiencing slight buying pressure.
GILD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.9 | Sell |
Relative Strength Index (14 RSI): | 50.12 | Buy |
Chaikin Money Flow: | 10367947 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (100.78 - 106.32) | Buy |
Bollinger Bands (100): | (93.92 - 110.04) | Buy |
RYTM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.04 | Buy |
Relative Strength Index (14 RSI): | 46.88 | Sell |
Chaikin Money Flow: | 27337 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (58.61 - 64.05) | Sell |
Bollinger Bands (100): | (52.9 - 60.74) | Buy |
GILD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 100.68 | Buy |
20-day SMA: | 103.48 | Buy |
50-day SMA: | 107.61 | Sell |
200-day SMA: | 92.88 | Buy |
8-day EMA: | 100.99 | Buy |
20-day EMA: | 102.95 | Buy |
50-day EMA: | 104.3 | Sell |
200-day EMA: | 94.9 | Buy |
RYTM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 62.08 | Sell |
20-day SMA: | 62.15 | Sell |
50-day SMA: | 56.78 | Buy |
200-day SMA: | 54.27 | Buy |
8-day EMA: | 61.17 | Sell |
20-day EMA: | 61 | Sell |
50-day EMA: | 58.76 | Buy |
200-day EMA: | 53.68 | Buy |
Gilead Sciences Earnings Growth & GILD Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.62 per share, a decrease next quarter of $0.08 per share, an increase this year of $3.57 per share, and an increase next year of $0.49 per share.
Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.17 per share, an increase this year of $1.44 per share, and an increase next year of $1.20 per share.
Gilead Sciences Technical Analysis
Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Rhythm Pharmaceuticals Technical Analysis
Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |